News

Sophie Cunningham Becomes New Ambassador for SHARx Advocacy

Sophie Cunningham Becomes New Ambassador for SHARx Advocacy

Sophie Cunningham Joins SHARx as Brand Ambassador

SHARx, a leading patient prescription advocacy company, enthusiastically announces the addition of WNBA star Sophie Cunningham to its national brand ambassador team. Marking a significant step in its mission, SHARx aims to highlight the pressing issues surrounding the accessibility of high-cost medications that burden many individuals across the nation.

Empowering the Rising Tide Army

Cunningham joins a growing alliance of ambassadors within the SHARx Rising Tide Army (RTA), a movement dedicated to raising awareness about the staggering costs of prescription drugs. SHARx's commitment to this cause resonates deeply, and Cunningham's involvement brings a new voice to this vital advocacy effort. Other dedicated ambassadors include notable figures from various fields, such as:

  • Heath Shuler, three-term Member of Congress and former first-round draft pick of the Washington Commanders.
  • Brock Osweiler, a standout from the 2016 Super Bowl champion Denver Broncos.
  • Steve Jones, a celebrated 1996 U.S. Open Champion.
  • Gary Hallberg, an accomplished professional golfer with eleven titles worldwide.

Cunningham's Message of Accessibility

In reflecting on her new role, Cunningham expressed concern over the challenges many face in accessing lifesaving medications due to high costs. "There are so many people who can't access lifesaving medication because of cost, and it's wrong," she stated. "SHARx is committed to changing that, and I am proud to use my platform to amplify their mission." Her passionate commitment amplifies the collective goal of SHARx, which focuses on breaking down barriers to medication access.

SHARx's Vision for Healthcare

Since its inception in 2017, SHARx has worked tirelessly to remove hindrances to prescription drug access through innovative supply chain management and education initiatives. Corey Durbin, the Chief Executive Officer of SHARx, emphasizes that patients remain the key stakeholders within the complex U.S. pharmaceutical landscape. "Our members are the patients who are at risk of getting lost in the complexities of the U.S. pharma system," Durbin remarked. With influencers like Cunningham, SHARx aims to raise awareness and advocate for change.

Pushing for Change Against High Drug Costs

According to research, American consumers often pay exorbitantly high prices for brand-name medications, with costs reported to be up to 422% more than consumers internationally. Paul Pruitt, Chief Growth Officer of SHARx, personally understands these challenges as two of his sons require medications costing over $2 million annually. He passionately advocates for lower drug prices and better access for all American consumers.

The Impact of Unaffordable Medications

Pruitt pointedly noted the struggles countless Americans face due to the high costs of medications, stating, "Being without coverage for medications should not force the consumer into a situation where they have to choose between medications and groceries." This crisis necessitates an urgent response, as many individuals are grappled with the financial burden of pharmaceuticals.

Championing Affordable Choices

SHARx’s foundation rests on enabling consumers to have access to affordable medication options, emphasizing the importance of well-informed consumer choices. "We built SHARx to provide more people with the power to make their own drug procurement choices, both domestically and internationally," Durbin explained. The partnership with Cunningham promises to champion the cause further, helping to spread awareness and provide hope to those in need.

About Sophie Cunningham

Sophie Cunningham is not only recognized for her impressive athletic achievements at the University of Missouri but also for her exceptional career in the WNBA. Holding multiple accolades, she was the third overall pick by the Phoenix Mercury in the 2019 draft. Cunningham's presence in media, including her podcast Show Me Something, showcases her engaging personality and commitment to addressing pressing societal issues.

About SHARx

Founded to combat the high prices of prescription drugs, SHARx implements ethical sourcing strategies to ensure that all individuals receive essential medications without hidden markups or unnecessary expenses. Their commitment to transparency and affordability continues to gain attention, driven by passionate leaders who prioritize the well-being of their members.

Frequently Asked Questions

What role does Sophie Cunningham play at SHARx?

Sophie Cunningham serves as a brand ambassador, advocating for affordable access to prescription medications.

Why is the Rising Tide Army important?

The Rising Tide Army is crucial for raising awareness about the challenges posed by high-cost medications and engaging communities in advocacy efforts.

How does SHARx help consumers access medications?

SHARx provides innovative solutions in drug procurement, focusing on delivering affordable medication options to individuals while promoting transparency.

What are the impacts of high prescription costs on consumers?

High prescription costs lead many consumers to forgo necessary medications, impacting their health and financial stability.

Where can I learn more about SHARx?

More information about SHARx's mission and services can be found on their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Mixx Unveils SxC™ Connector for Enhanced Connectivity

Updated Category News Views 5

Game-Changer in Optical Connectivity: Meet SxC™ In the no-frills world of hyperscale data centers, where connectivity needs to keep pace with leaps in AI, Mixx Technologies is stepping up with something big—the SxC™ Connector. We're talking about fitting a mind-boggling 24,576 fibers in a single rack unit. This isn't just tinkering at the edges; it's rewriting the...

Continue Reading
Brinker International's Investor Day: Key Insights

Updated Category News Views 7

Diving Into Brinker's Strategic Vision Looks like Brinker International (NYSE: EAT) is rolling out the red carpet for its Investor Day on September 17, 2026. Set at their Dallas headquarters, they’re ready to spill the beans on what’s steering them forward. So, if you’ve marked your calendars, know it’s gonna be a tight circle in there—invitation-only gig,...

Continue Reading
Sealaska: Building Prosperity with Traditional Values

Updated Category News Views 2

Traditional Values Meet Modern Enterprise The world does a double-take whenever Indigenous values meet business might, but here comes Sealaska proving they’re more than capable at uniting both fronts. Founded under the Alaska Native Claims Settlement Act (ANCSA) in 1971, this behemoth of Southeast Alaska is synchronizing age-old wisdom with cutting-edge business acumen,...

Continue Reading
Idaho Riverfront Mansion Heads to Auction for Charity

Updated Category News Views 0

Idaho Mansion Auction: A Charitable Move They say home is where the heart is, but sometimes, a house becomes something more—a vessel for goodwill. That's precisely what's happening in American Falls, Idaho. An upscale riverfront estate, previously listed for a hefty $3.86 million, is hitting the auction block come September 17, stripped of any reserve pricing. This...

Continue Reading
EQT's Strategic Share Buybacks Signal Market Confidence

Updated Category News Views 2

Decoding EQT's Buyback Blitz Ah, stock buybacks—one of the market's spicy little pleasures. EQT AB is up in Stockholm making moves, gobbling up 680,980 of its own shares between August 24th and 28th, 2026. Why does this matter? Two words: market confidence. When a company scoops up its own shares, it’s a bit like a pat on its own back, saying 'we're worth it.' The...

Continue Reading
UWM Faces Lawsuit After $603M Derivatives Loss

Updated Category News Views 8

Stumbling Over Hedges: The UWM Story If you're a UWM Holdings Corporation (NYSE: UWMC) investor, the recent noise around their financials might feel like a punch to the gut. Let's break it down. UWM found themselves sailing in harsh waters with the announcement of massive financial losses that came as a surprise after their high-stakes gambles went sour. Suddenly, the...

Continue Reading
Astellas Joins U.S. Effort for Drug Access and Innovation

Updated Category News Views 7

Astellas Pharma, well-known but not yet household famous, just struck a deal with Uncle Sam. Let me tell you, it's not just ink on paper—it's a move that could shake up how the U.S. does meds. Think of it as one of those rare cases where Pharma cozies up with government to actually do something that's supposed to help us regular folks. But hold your applause, there's...

Continue Reading
VIN Foundation's Generous Push for Vet Education in 2027

Updated Category News Views 0

Scholarships Fueling Future Veterinarians Not a day goes by without someone singing the praises of VIN Foundation's efforts. This time, they're spotlighting two fresh souls embarking on their vet school journey. Mark it, folks, the 2027 Mike Dunn, DVM Veterinary Student Scholarship, birthed by Becky Godchaux, is here to soften the financial blow. Up to $140,000 per head...

Continue Reading
Recognizing When Manual Processes Limit Growth

Updated Category News Views 5

Spotting Manual System Limits in Business Growth Ever tried stuffing a square peg in a round hole? That's what sticking with outdated manual processes can feel like when business gears start turning faster than your current setup can handle. Gathering the nuggets from expert Matt Lepkowski, let's chew on recognizing when a business's manual gears are grinding against...

Continue Reading
Jack Henry Dodges Cyber Bullet; Clients Stay Secure

Updated Category News Views 2

When Cyberstorms Hit, How Do You Stay Upright? It feels like every other day, we're hearing about another cybersecurity mess some firm found themselves in. And there we have Jack Henry, bravely stepping into the spotlight. They just dropped the news about how they contained a right nasty piece of business—a phishing scheme that tried to worm its way into their systems....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Proposed Sale of Veeco Instruments Inc.: Key Insights

Updated Category News Views 92

Understanding the Proposed Sale of Veeco Instruments Inc. In recent developments, Veeco Instruments Inc. is set to be sold to Axcelis Technologies, under a proposed deal involving the exchange of shares. This potential acquisition has sparked interest among shareholders who are keen to understand the implications of this transaction. The Deal Overview According to the...

Continue Reading
Kintara Therapeutics Invites Stockholder Participation in Merger

Updated Category News Views 52

Kintara Therapeutics Invites Stockholders to Participate in Merger Kintara Therapeutics, Inc. (NASDAQ: KTRA), an innovative biopharmaceutical company, is actively engaging its stockholders in a crucial decision regarding a proposed merger with TuHURA Biosciences, Inc. This merger aims to strengthen their oncology pipeline by leveraging combined expertise and resources....

Continue Reading
FirstEnergy Corp. Maintains Quarterly Dividend at $0.425 Per Share

Updated Category News Views 52

FirstEnergy Corp. Keeps Quarterly Dividend Steady for Shareholders FirstEnergy Corp. (NYSE: FE) has announced it will maintain its quarterly dividend at a robust $0.425 per share. This consistent choice highlights the company’s dedication to its shareholders and its sound financial management practices that guide its operations. Dedication to Shareholders This dividend...

Continue Reading
Treasure Global's Journey to 500% Revenue Growth by 2026

Updated Category News Views 151

Treasure Global's Focus on Explosive Revenue Growth Treasure Global Inc. (NASDAQ: TGL), a company nestled in Southeast Asia's vibrant technology sector, has set its sights on an ambitious goal for the coming years. The firm is forecasting a staggering increase in revenue for 2026, aiming for more than 500% growth. This optimistic projection stems from several operational...

Continue Reading
RB Global Inc: Insights on Market Support and Short Interest

Updated Category News Views 139

Examining RB Global Inc's Market Support RB Global Inc's (NYSE:RBA) recent market performance indicates a shift in trader sentiment, specifically reflected in the short interest data. The latest figures reveal a decline of 6.78% in short interest since the last report, which suggests that traders are becoming less bearish on the stock. Currently, approximately 7.65...

Continue Reading